Intestinal absorption test using 13C-labeled compounds

Intestinal absorption test using 13C-labeled compounds - Intestinal absorption test using 13C-labeled compounds

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014792

Enrollment

110

Registered

2014-08-08

Start date

2014-08-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic steatohepatitis

Interventions

Using endoscopy, we spray 13C labeling reagent in duodenum. 13C labeling reagent consists of mixture of 13C- palmitic acid 200mg and 20ml RACOL&amp

reg

.Patients&#39

breath is collected up to 360 minutes every 30 minutes. Then, the 13CO2 in exhaled breath is measured using an infrared spectrometer UBit-IR200.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy people or patients with metabolic syndrome including NASH

Exclusion criteria

Exclusion criteria: Egg-allergic patient Patients that can not perform properly breath sampling Patients that can not perform upper gastrointestinal endoscopy because of systemic state Patients with chronic liver disease other than NASH

Design outcomes

Primary

Measure	Time frame
nothing	—

Countries

Japan

Contacts

Public ContactHiroki Utsunomiya

Ehime University Graduate School of Medicine Departments of Gastroenterology and Metabology

lopp_august@yahoo.co.jp0899605308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026